Home Search
cannabis - search results
If you're not happy with the results, please do another search
Up in smoke: Understanding knowledge gaps for cannabis edibles
Michael A. Rogers outlines four necessary elements to increase further societal understanding about the use of cannabis edibles.
The cultivation of sustainable and organic medical cannabis in controlled environments
CEO of OC Care ApS, Christian Ohlendorff Hollensen, illuminates us on what we need to know about the cultivation of sustainable and organic medical cannabis in controlled environments, including the essential factor of lighting.
Professor Mike Barnes: The future of medical cannabis is real
We spoke to Professor Mike Barnes, to discuss the future of medical cannabis and cut through the fake news saturating the field.
Malta’s stance on cannabis for medicinal and research purposes
Here, the Malta Medicines Authority (MMA) shares a vision which integrates regulatory sciences, innovation, and academic initiatives.
The FDA’s 2020 Cannabis policy
Here, Ann Allworth discusses what lies ahead for the FDA’s 2020 Cannabis policy and highlights discrepancies in their thinking.
Cannabis (hemp): The effect of terpenes in CBD full extracts
Cannabis (hemp) contains up to 150 different terpenes. They not only determine the smell, but they also have valuable properties for the body as studies show. Katharina Zedlacher, from BioBloom GmbH, discusses the effect of terpenes in CBD full extracts.
Topical Cannabis-Based Medicines (TCBM): A novel epigenetic paradigm for wound management
Dr Vincent Maida discusses his discoveries and pioneering research in the area of using Topical Cannabis-Based Medicines (TCBM) for integumentary and wound management.
Addressing how cannabis businesses are banked: Room for improvement?
With attention turning in the U.S. and elsewhere to how cannabis businesses are banked, John Binns, Partner at BCL Solicitors LLP, gets into the weeds of how UK banks have been addressing the issue, as well as the prospects for improvement.
Cannabis-based medicines as a treatment for epilepsy in the UK
Sam Mountney, Senior Policy & Campaigns Officer at Epilepsy Action, shares his expertise on cannabis-based medicines as a treatment for epilepsy in the UK.
How can cannabis help in treating anxiety?
Today, people use cannabis products such as CBD for numerous medicinal benefits, here we find out how it can help in treating anxiety.
The medical cannabis market in Denmark & Europe
Investment Manager at the Ministry of Foreign Affairs of Denmark, Michael Prytz, charts the rapid development of the medical cannabis market in Europe and provides a look at the Danish model in this vein.
What next for the UK’s cannabis laws?
John Binns, Partner at BCL Solicitors LLP looks at the UK’s cannabis laws and how they could be improved.
IP protection in fast-moving global markets: Medical cannabis & CBD
Laura Clews, Managing Associate at IP attorneys Mathys & Squire, analyses the protection for innovative new products in the medical cannabis & CBD sector.
From Cannabis flower to final products: Extractions for Phytopharmaceuticals
Dr Nikos Xynos, PhD in Pharmaceutical Sciences/Natural Products Chemistry and MD a Nomad Labs, explores the various pathways to cannabinoid extraction, refining and purification technologies.
Medicinal cannabis: What the UK can learn from Denmark
Spectrum Therapeutics UK lifts the lid here on a pilot analysis of medicinal cannabis use that will run in Denmark until January 2022.
The UK’s medical cannabis industry
Dr. Frank D'Ambrosio, CMO of Block Commodities Plc, provides an insight into the UK’s medical cannabis industry.
How important is light for the cultivation of medical cannabis?
Here, Christoph Schubert discusses how light is one of the most important factors in the professional cultivation of medical cannabis.
The value of accreditation in the cannabis industry
Chris Gunning, General Manager – Accreditation Services at A2LA, discusses the value of accreditation in today’s cannabis industry.